Introduction
The anaemia of chronic renal failure is commonly normocytic and normochromic. Iron-deficiency anaemia may occur and when transfusion is avoided is not u;ncommon in patients undergoing regular dialysis therapy. Controversy exists regarding the effectiveness of oral iron therapy in such patients resulting in the advocacy of prolonged parenteral iron therapy (Crockett et al., 1967) . Such treatment can, however, result in iron overload (Curtis et al., 1969) .
The present study was undertaken to re-examine both the absorption of oral iron and the utilization of oral and intravenous iron in patients undergoing membrane dialysis who were carefully studied with respect to intercurrent iron loss.
Methods and Patients
Thirteen patients on regular dialysis therapy for 3 to 34 months were studied. All were dialysed for a minimum of 28 hours weekly with a Kiil dialyser. They were in good health and received no haematinics at the time of the isotope studies. Two patients (Cases 6 and 13) had had 750 mg and 1,000 mg of iron intravenously 18 and 15 months before the investigation. Case 13 had had 12 pints (6.8 litres) of blood, Case 4 5 pints (2.8 litres), Cases 1, 2, 6 and 11 each 2 pints (1.1 litres) previously. The details of diagnosis are given in Table I .
The haemoglobin and packed cell volume (P.C.V.) were measured at the beginning of the study, after each dialysis, and before and after iron therapy by methods described by Dacie and Lewis (1968) ; serum iron was measured by an automated micromethod (Garry and Owen, 1967) and ironbinding capacity by a semiautomated micromethod (Brozovich and Copestake, 1969) . Serum and whole blood folate levels were measured by an automated method described by Millbank et al. (1970) . Reticulocyte uptake of iron in vitro has been shown to be a sensitive guide to iron deficiency and was carried out by the method of Brozovich (1971) . The use of automated micromethods for all of these determinations reduced the amount of blood taken from these patients to a minimum.
Bone marrow specimens were obtained before the study began and again after iron therapy. They were stained for iron by the method of Rath and Finch (1948) . Each was independently examined and graded for its iron content by two of us (J.S.M. and A.S.).
The absorption studies were carried out by means of a whole body counting technique using four Nal (Ti) crystals in a shielded room (Cottrall et al., 1968) . Pulse height analysis A second method of measuring absorption was also used (Cottrall and Trott, 1971) . A non-absorbable 5tCr chromic chloride marker was given half an hour after the 59Fe. Faecal collection was carried out over the next few days, and the percentage of iron and chromium measured. The amount of iron absorbed was then calculated, assuming that both tracers were intimately mixed, and passed through the gut at the same rate. A similar method for measuring iron absorption with l3lBa as the insert marker has been reported (Najean and Ardaillou, 1963; Boender and Verloop, 1969) .
The blood clearance half-time of intravenously administered 59Fe was then measured. 5"Cr-labelled red cells, given at the same time as the 59Fe, enabled the red cell mass to be determined simultaneously and reduced the amount of blood taken-8 ,uCi of "9Fe and 50 uCi of 51Cr were used.
Studies of the loss of iron from these patients were started two weeks later, after the completion of the utilization of the intravenous iron estimation, and were carried out by a method similar to that of Holt et a]. (1967, 1968) . Whole body counting was done at intervals of 14 and then 21 days up to a total of not less than 98 days. In seven of the patients all dialysis lines and membranes, dressings used at the time of attention to the shunts, and blood clots were carefully collected and incinerated; the radioactivity in the ash that had accumulated during the 21-day period was measured, two opposed NaI (T1) crystals in a shielded enclosure being used.
Haematological Studies All patients were anaemic with haemoglobin levels ranging from 5-2 to 11 g/100 ml (Table I) . P.C.V.s ranged from 18 to 33 %. The red cell masses were low, ranging from 507 to 1,230 ml. Good correlation was seen between the red cell mass and the P.C.V. (Fig. 1) The mean daily loss of iron given as a percentage of the mean total body count was found to be in the range 0.02 to 1.3% per day, with a standard deviation due to counting statistics usually less than 0.01% per day. The loss of iron in control subjects using this method is 0-03% per day (Holt et al., 1967) . In 11 patients who completed these studies two (Cases 6 and 10) showed normal daily iron loss (0*02 to 0-04% per day), five (Cases 3, 7, 8, 12 , and 13) showed intermediate losses (0.14 to 0-25% per day), and the other four (Cases 1, 2, 5, and 9) showed heavy iron loss (0.3 to 1-3 % per day). This loss was not uniform over the period of the study (Fig. 3 ).
Standard deviations due to counting statistics: * < 1 0.; t as indicated
The mean retention of iron in the patients on renal dialysis who were anaemic but not iron deficient was 11.3%. The mean retention of iron in the seven iron-deficient patients was 31-2%, and five out of seven showed levels of retention seen in the iron-deficient control subjects though the values tended to the lower part of the range. Retention of iron diminished as the marrow iron stores increased (Fig. 2) . The steep fall in the activity in Cases 2 and 5 between the second and fifth week was related to clotting of the shunt and menorrhagia in Case 5 and a bleed into the dialyser in Case 2. The variation in the volume of blood lost into the membranes and lines in seven patients is shown in Table IV .
The very big losses relate to accidents, but losses of between 5 and 20 ml were common and indicate how easily iron deficiency can develop insidiously in these patients. The absorption of iron measured by the chromium chloride marker technique showed poor correlation with the retention values even in the iron-deficient patients where agreement had been good in previously reported studies. Reproducibility of results from successive daily samples was also poor. It is possible that there is poor mixing of the iron and chromium in these patients who take an unusual diet.
The utilization of the orally ingested iron for haemoglobin formation was greater than 45% in all patients except the iron-laden patient (Case 13). Though the utilization of "5Fe was less than that sometimes seen in iron-deficient nonuraemic subjects, nevertheless 66 to 78% was available in the iron-deficient group for haemoglobin formation. The discrepancy between the utilization of the oral wFe and intravenous 59Fe was notable in Cases 5 and 6 where the latter was less well utilized. In four patients (Cases 9, 10, 12, and 13 These studies show that patients on regular dialysis who are iron deficient will respond to oral iron therapy, and also that in these patients the state of the body's iron stores still influences absorption. The marrow iron stores are the most valuable guide to the need for treatment with iron and this confirms the observations of Edwards et al. (1970) . The level of absorption in our iron-deficient patients did not approach those reported by Escbach et al. (1970) . The two groups of patients may not be comparable, but their finding that iron absorption was entirely compatible with their patients' requirements was not confirmed in this study. The failure of the patients in the present study to replenish their marrow iron stores suggests that prolonged therapy may be required by those on regular renal dialysis.
Utilization of iron for haemoglobin formation occurred at the rate seen in the studies on intravenous iron by Carter et al. (1969) , but there is no evidence that parenteral iron only was capable of being utilized. Parenteral iron is not more effective, and unless the requirement is carefully calculated and the result of treatment assessed from the marrow iron serious overload may develop
The rate of blood loss varied considerably in these patients, and individuals could show pronounced variation in mean loss at dialysis in successive periods. The patient with the insidious loss of from 5 to 30 ml of blood per dialysis is most at risk as this may not be appreciated. It is in this group that prolonged oral iron therapy would be beneficial.
